SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
North American Vaccine
An SI Board Since April 1997
Posts SubjectMarks Bans Symbol
507 2 0 NVX
Emcee:  Don W Stone Type:  Unmoderated
To all: From the Baltimore SUN, dtd April 18 , 1997

"Dr. Sharon Mates, North American Vaccine president, is honored as High Tech Executive of the year. She credits forebearance for her success in biotechnology."

"Patience is an absolute skill needed for this job." said Mates.

"Mates was named High Tech Executive of the Year by the Suburban Maryland High Technology Council, a regional industry trade group. She was chosen from a field of 90 nominees."

The article goes on to say that She earned credit for building North American Vaccine from a research oriented firm into a recognized vaccine manufacturer, one of just five in the U.S.

The title of the article: " THE SCIENCE OF PATIENCE "

We'll all be rewarded if we practice it. :-}

Congratulations Sharon, from all of us.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
507 Close the doors Baxter Completes Acquisition of North American Vaccine DEERFIELPaul Lee-6/26/2000
506 NORTH AMERICAN VACCINE, INC. 10150 Old Columbia Paul Lee-5/25/2000
505 North American Vaccine and Baxter Agree to Modify Share Exchange Agreement COLPaul Lee-4/17/2000
504 Excellent Antibody Response of North American Vaccine's Hib Vaccine In Pre-Paul Lee-1/28/2000
503 North American Vaccine Files for UK Regulatory Approval of NeisVac-C(TM) COLUMPaul Lee-1/24/2000
502 North American Vaccine Expects to File the NeisVac-C(TM) UK License ApplicationPaul Lee-1/18/2000
501 Baxter Intl Gets Antitrust Okay For N Amer Vaccine Buy WASHINGTON -- Baxter Paul Lee-12/28/1999
500 KO: Maybe tax losses for those who want to realize them this year. David David Bogdanoff-11/19/1999
499 Would have thought this announcement would push the stock at least to the $6.75Ken O'Connor-11/18/1999
498 North American Vaccine Agrees to be Acquired by Baxter International Inc. COLUPaul Lee-11/18/1999
497 Buy outKen O'Connor-10/6/1999
496 such as Paul Lee-10/5/1999
495 Patience guys, the bad news is over now, the good news still to come so I underKen O'Connor-10/5/1999
494 can't help on that Paul Lee-10/5/1999
493 Paul, do you happen to know if the facility that NVX sold, on a lease back, a fRick Strange-10/5/1999
492 this is ugly Abbott Laboratories Ends Certiva(TM) Marketing Agreement; NeisVacPaul Lee-10/5/1999
491 As I mentioned, NVX doing some big things price wise (ok a little later then anKen O'Connor-9/17/1999
490 Some big purchases today.........hummmmmmmmmmmmmm Regards KenKen O'Connor-9/3/1999
489 North American Vaccine Comments on Stock Price COLUMBIA, Md., Aug. 25 /PRNewswPaul Lee-8/25/1999
488 Let the bidding begin....... Regards KenKen O'Connor-8/23/1999
487 Would you care to share those "things"? Either here or in a PM Paul Lee-8/17/1999
486 I hear we may see lots of activity over the next 1 - 2 weeks. Things are happeKen O'Connor-8/16/1999
485 BioChem Pharma, N Amer Vaccine In Confidentiality Pact WASHINGTON -- BioChemPaul Lee-8/13/1999
484 See news, company announces quarterly results (.40) and updates status of currePaul Lee-8/9/1999
483 BioChem Pharma To Mull North America Vaccine Options By CHRISTOPHER J. CHIPPaul Lee-7/29/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):